Sort
10,766 grants matching “checkpoint inhibitor”
The Role of hPso4 in DNA Repair and Chemotherapy Resistance
$135,657Montaser Shaheen · University Of New Mexico Health Scis Ctr · K01 · FY2014 · HL
A Two Hybrid System Based Yeasy Screen for Agents that Affect DNA Damage Checkpoi
$135,446Nalin Kumar · Uhv Technologies, Inc. · R43 · FY2007 · CA
Targeting mechanical regulation of monocyte fate in head and neck cancer.
$135,000Kyle Holmberg Vining · Dana-Farber Cancer Inst · K99 · FY2022 · DE
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$134,795Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2018 · CA
Innate-like lymphocyte regulation of host-microbiota interactions in cancer
$134,574Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$134,574Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Regulation of Telomerase by NFX1
$134,379Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · K08 · FY2012 · CA
Regulation of Telomerase by NFX1
$134,379Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · K08 · FY2008 · CA
Regulation of Telomerase by NFX1
$134,379Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · K08 · FY2011 · CA
Regulation of Telomerase by NFX1
$134,379Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · K08 · FY2009 · CA
Regulation of Telomerase by NFX1
$134,379Rachel Adria Katzenellenbogen · Seattle Children'S Hospital · K08 · FY2010 · CA
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD
$134,365Richard M Longnecker · Northwestern University At Chicago · R01 · FY2010 · CA
Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
$134,250Naoka Murakami · Brigham And Women'S Hospital · R03 · FY2023 · DK
Role of antigen-specific T cells in immunotherapy-associated acute interstitial nephritis and kidney allograft rejection
$134,250Naoka Murakami · Brigham And Women'S Hospital · R03 · FY2022 · DK
PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells
$134,173Hyeonjoo Cheon · Wayne State University · R21 · FY2022 · CA
Targeting Cell Cycle Checkpoints in Cancer Therapeutics
$133,893Archie N Tse · Sloan-Kettering Inst Can Research · K08 · FY2009 · CA
Targeting Cell Cycle Checkpoints in Cancer Therapeutics
$133,893Archie N Tse · Sloan-Kettering Inst Can Research · K08 · FY2006 · CA
Targeting Cell Cycle Checkpoints in Cancer Therapeutics
$133,893Archie N Tse · Sloan-Kettering Inst Can Research · K08 · FY2008 · CA
Targeting Cell Cycle Checkpoints in Cancer Therapeutics
$133,893Archie N Tse · Sloan-Kettering Inst Can Research · K08 · FY2007 · CA
Structure and Function of SET Domain Methyltransferases
$133,753Raymond C Trievel · University Of Michigan At Ann Arbor · R01 · FY2009 · GM
Clinical Studies to Circumvent Drug Resistance
$133,716Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Cardiovascular Diseases among Patients with Cancer and Patients living with HIV
$133,685Tomas G Neilan · Massachusetts General Hospital · K24 · FY2025 · HL
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$133,520James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA
IDENTIFYING INHIBITORS OF THE APC/C USING YEAST MUTANTS
$133,200University Of Virginia Charlottesville · R21 · FY2000 · CA
IDENTIFYING INHIBITORS OF THE APC/C USING YEAST MUTANTS
$133,200University Of Virginia Charlottesville · R21 · FY2001 · CA